Deutsche Bank Downgrades AstraZeneca (AZN) to Hold
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Deutsche Bank Downgrades AstraZeneca (AZN:LN) (AZN) to Sell
February 8, 2024 5:36 AM ESTDeutsche Bank analyst Emmanuel Papadakis downgraded AstraZeneca (AZN:LN) (NASDAQ: AZN) from Hold to Sell with a price target of GBP95.00 (from GBP110.00).
... MoreAstraZeneca (AZN) Tops Q4 EPS by 71c; initiates guidance
February 8, 2024 2:55 AM ESTAstraZeneca (NASDAQ: AZN) reported Q4 EPS of $1.45, $0.71 better than the analyst estimate of $0.74. Revenue for the quarter came in at $12.02 billion versus the consensus estimate of $12 billion.
GUIDANCE:
The Company issues its Total Revenue and Core EPS guidance for... More
SOPHiA GENETICS (SOPH) and AstraZeneca Spain (AZN) Commit to Increasing Ovarian Cancer Testing in Spain
February 7, 2024 6:53 AM ESTSOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced it has expanded an existing program in Spain to increase access to local testing for homologous recombination deficiency (HRD) throughout the country. The expansion of the program, supported by AstraZeneca (NASDAQ: AZN) Spain and its network throughout the country, will further SOPHiA GENETICS' commitment to global health... More
